| Medical and Health Sciences | 2021-2025 | 325 | US 115 | 99.93 |
| Cardiology and Cardiovascular Medicine | Lifetime | 375 | US 215 | 99.52 |
| Nephrology | Lifetime | 85 | US 48 | 99.42 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 467 | US 254 | 98.60 |
| Hematology | Lifetime | 788 | US 387 | 92.73 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 34 | US 23 | 99.62 |
| Nephrology | 2021-2025 | 58 | US 23 | 98.16 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 235 | US 113 | 98.15 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 485 | US 162 | 94.72 |
| Hematology | 2021-2025 | 368 | US 170 | 79.92 |
| Hemodynamic Monitoring and Therapy | Lifetime | 62 | US 20 | 99.40 |
| Dialysis and Renal Disease Management | Lifetime | 65 | US 31 | 99.57 |
| Blood Pressure and Hypertension Studies | Lifetime | 136 | US 61 | 99.48 |
| Hormonal Regulation and Hypertension | Lifetime | 190 | US 75 | 98.95 |
| Erythropoietin and Anemia Treatment | Lifetime | 74 | US 32 | 98.54 |
| Chronic Kidney Disease and Diabetes | Lifetime | 182 | US 86 | 98.90 |
| Cardiovascular Health and Disease Prevention | Lifetime | 280 | US 126 | 98.55 |
| Diabetes Treatment and Management | Lifetime | 381 | US 154 | 98.55 |
| Heart Rate Variability and Autonomic Control | Lifetime | 522 | US 247 | 98.29 |
| Hemoglobinopathies and Related Disorders | Lifetime | 366 | US 185 | 97.89 |
| Electrolyte and hormonal disorders | Lifetime | 212 | US 104 | 97.72 |
| Central Venous Catheters and Hemodialysis | Lifetime | 332 | US 145 | 97.58 |
| Renal function and acid-base balance | Lifetime | 240 | US 126 | 97.31 |
| Iron Metabolism and Disorders | Lifetime | 449 | US 207 | 97.29 |
| Renal and Vascular Pathologies | Lifetime | 469 | US 258 | 97.28 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 334 | US 155 | 96.88 |
| Sodium Intake and Health | Lifetime | 174 | US 84 | 97.07 |
| Heart Failure Treatment and Management | Lifetime | 869 | US 389 | 97.08 |
| Potassium and Related Disorders | Lifetime | 209 | US 106 | 96.03 |
| Muscle and Compartmental Disorders | Lifetime | 406 | US 161 | 92.97 |
| Hormonal Regulation and Hypertension | 2021-2025 | 13 | US 7 | 99.46 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 43 | US 17 | 99.01 |
| Diabetes Treatment and Management | 2021-2025 | 83 | US 42 | 99.07 |
| Electrolyte and hormonal disorders | 2021-2025 | 15 | US 6 | 97.82 |
| Dialysis and Renal Disease Management | 2021-2025 | 81 | US 19 | 98.03 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 98 | US 34 | 97.25 |
| Diet and metabolism studies | 2021-2025 | 532 | US 160 | 95.05 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 76 | US 27 | 91.99 |
| Potassium and Related Disorders | 2021-2025 | 140 | US 58 | 88.35 |
| Sodium Intake and Health | 2021-2025 | 476 | US 116 | 72.36 |
| Ion Transport and Channel Regulation | 2021-2025 | 350 | US 106 | 70.24 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 889 | US 235 | 54.73 |